Attributes | Values |
---|
rdf:type
| |
Description
| - The results presented here show that despite the wellknown advantages of immunoassays in screening analysis of urine for drugs of abuse (including BZD), it is necessary to confirm practically all benzodiazepine results obtained in this way. Immunochemical screening of urine should be always followed by identification of BZD and their metabolites in urine or better in both urine and gastric contents using e.g. TLC, GC-MS and subsequent BZD confirmation/quantitation in blood, for example using GC-ECD. Only complex toxicological analysis of biological material (urine, gastric contents and blood) using immunochemical as well as chromatographical methods permits toxicological laboratories to give valid interpretation of results, thus contributing to objective evaluation of the level of intoxication in forensic as well as clinical practice.
- The results presented here show that despite the wellknown advantages of immunoassays in screening analysis of urine for drugs of abuse (including BZD), it is necessary to confirm practically all benzodiazepine results obtained in this way. Immunochemical screening of urine should be always followed by identification of BZD and their metabolites in urine or better in both urine and gastric contents using e.g. TLC, GC-MS and subsequent BZD confirmation/quantitation in blood, for example using GC-ECD. Only complex toxicological analysis of biological material (urine, gastric contents and blood) using immunochemical as well as chromatographical methods permits toxicological laboratories to give valid interpretation of results, thus contributing to objective evaluation of the level of intoxication in forensic as well as clinical practice. (en)
|
Title
| - Benzodiazepines in clinical and forensic analysis
- Benzodiazepines in clinical and forensic analysis (en)
|
skos:prefLabel
| - Benzodiazepines in clinical and forensic analysis
- Benzodiazepines in clinical and forensic analysis (en)
|
skos:notation
| - RIV/61989592:15110/07:10223813!RIV12-MSM-15110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/07:10223813
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - GC-MS; GC-ECD; FPIA; determination; identification; benzodiazepines (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Ondra, Peter
- Válka, Ivo
- Zedníková, Kateřina
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |